腺病毒於禽流感M2疫苗發展之評估

Evaluation of M2-based avian influenza virus vaccine using an adenovirus vector

林淑萍(Shu-Ping Lin)

指導教授 ： 王金和

共同指導教授 ： 鄭益謙(Ivan-Chen Cheng)

國立臺灣大學/獸醫專業學院/獸醫學研究所/碩士(2012年)

https://doi.org/10.6342/NTU.2012.02902

摘要

一般商業化之家禽流行性感冒病毒之疫苗對於不同HA亞型之家禽流行性感冒病毒感染無交叉保護力。因此，本實驗以發展具交叉保護之疫苗為目的，利用複製缺陷腺病毒 (replication deficient adenovirus) 作為載體，建構帶有不同亞型間保守度高之M2基因片段的重組腺病毒 (Ad/M2)，再將Ad/M2免疫雞隻。Ad/M2感染之293A細胞及轉導之Vero細胞以間接螢光免疫分析皆有陽性訊號產生。在Ad/M2免疫雞隻的實驗結果顯示，補強後2週CD4+及CD8+ T cell相較於初次免疫有顯著增加；抗M2特異性抗體則於初次免疫後2週有顯著增加，但補強後的抗體上升效果則不明顯。於攻毒後第4天及第7天採集的喉頭拭子之real time RT-PCR結果顯示免疫組與對照組之間的AIV含量沒有差異，而攻毒後免疫組與對照組死亡率分別為40%及33.3%，給予Ad/M2之組別並無法對抗AIV感染。

關鍵字

家禽流行性感冒病毒 ； 複製缺陷腺病毒 ； M2

並列摘要

Current vaccines to avian influenza virus can’t induce broad cross-protection against different subtypes. Therefore, the purpose of this research was to develop a vaccine which can confer cross-protection by using replication-deficient adenovirus as a vector to construct a recombinant adenovirus carrying highly conserved M2 gene (Ad/M2). The immunofluorescence assay revealed positive signal in 293A and Vero cells transduced with Ad/M2. The Ad/M2 was intranasally and intramuscularly immunized in chickens twice at a 4-week interval. Anti-M2 specific antibody was significantly higher after two weeks post primary vaccination. Challenging with AIV after two weeks post boost vaccination, the consequence of real time RT-PCR revealed AIV content was no difference between Ad/M2 group and control group in oropharyngeal swab on day 4 and day 7 post challenge. The mortality of Ad/M2 group and control group was 40% and 33.3% respectively. The conclusion is giving chickens Ad/M2 couldn’t confer protection against AIV infection.

並列關鍵字

avian influenza virus ； replication deficient adenovirus ； M2

參考文獻

Ada, G.L., Perry, B.T., 1954. The nucleic acid content of influenza virus. Aust. J. Exp. Biol. Med. Sci. 32(4), 453-468.

Alexander, D.J., 2000. A review of avian influenza in different bird species. Vet. Microbiol. 74(1-2), 3-13.

Austin, F.J., Webster, R.G., 1986. Antigenic mapping of an avian H1 influenza virus haemagglutinin and interrelationships of H1 viruses from humans, pigs and birds. J. Gen. Virol. 67 ( Pt 6), 983-992.

Bakkouri, K.E., Descamps, F., De Filette, M., Smet, A., Festjens, E., Birkett, A., Van Rooijen, N., Verbeek, S., Fiers, W., Saelens, X., 2011. Universal Vaccine Based on Ectodomain of Matrix Protein 2 of Influenza A: Fc Receptors and Alveolar Macrophages Mediate Protection. J Immunol. 186(2), 1022-1031.

Blaas, D., Patzelt, E., Kuechler, E., 1982. Identification of the cap binding protein of influenza virus. Nucleic Acids Res. 10(15), 4803-4812.